About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Once-a-Day Epilepsy Drug Prevents Seizures as Well as Twice-a-Day Drug

by Dr. Trupti Shirole on April 17, 2016 at 8:54 PM
Font : A-A+

 Once-a-Day Epilepsy Drug Prevents Seizures as Well as Twice-a-Day Drug

Epilepsy is a common neurological disorder that can affect people of all ages. A new study suggests that an epilepsy drug that can be taken once a day may control seizures as well as a drug that must be taken twice a day, revealed a preliminary study that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

The study compared the once-a-day drug eslicarbazepine acetate to the twice-daily drug carbamazepine for people newly diagnosed with partial seizures, which start in one area of the brain.

Advertisement


"Seizure control is crucial," said study author Elinor Ben-Menachem, of Gothenburg University in Gothenburg, Sweden, and a member of the American Academy of Neurology. "A once-a-day drug may help people stick to their medication schedule." For the study, 815 people newly diagnosed with partial seizures received either eslicarbazepine or carbamazepine for about six months. Participants started the study at the lowest of three dosing levels. Those who had a seizure at the lowest level were then moved up to the second dosing level. If they had another seizure, they received the highest dosing level.

A total of 71% of those taking eslicarbazepine and 76% of those taking carbamazepine were seizure-free after six months. After one year, 65% of those taking the once-daily drug were seizure-free compared to 70% of those taking the twice-daily drug.
Advertisement

The study was what is called a non-inferiority study, which is designed to show that a new treatment is not clinically worse than an existing treatment. According to the study design, eslicarbazepine would be considered 'non-inferior' if the difference in seizure-free rate between the two drugs was 12% or lower. At six months, the difference was 4%. At one year, the difference was 5%.

"Memory issues, fatigue, or a complicated medication schedule can all interfere with a person taking their seizure-control medications on a regular basis so having a once-daily option for patients, especially when they are newly diagnosed and still learning to manage the disease, may be beneficial," said Ben-Menachem. "The hope is that these results may also give doctors more options to better tailor treatments for people with epilepsy."

Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Epilepsy Febrile Fits / Febrile Convulsions Neurocysticercosis Signature Drug Toxicity Drugs Banned in India Reye’s Syndrome Convulsions Electroencephalogram Aicardi-Goutieres Syndrome 

Most Popular on Medindia

Noscaphene (Noscapine) The Essence of Yoga Daily Calorie Requirements Nutam (400mg) (Piracetam) Drug - Food Interactions Blood Donation - Recipients Blood Pressure Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Pregnancy Confirmation Calculator Sanatogen
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Once-a-Day Epilepsy Drug Prevents Seizures as Well as Twice-a-Day Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests